A similar pattern of plasma ADA iso-enzyme activities was maintained in HR+HER2- BC according to the rate of cancer development, but only a tendency in increased ADA1 activity and ADA1/ADA2 ratio was observed (Figure 5C). The gene discussed is ERBB2; the disease is breast cancer.